VIEWPOINTS


Viewpoints are a collection of news and opinion articles that capture key research developments and important issues in the field of oncology.


Seven States Pass Some Form of Marijuana Legalization

Seven States Pass Some Form of Marijuana Legalization

CTA spoke with Judith A. Paice, PhD, RN, to better understand how clinicians are reacting to these legalizations and how she responds to patients asking about cannabis use.

Developing microRNA Biomarkers for Prostate Cancer

Developing microRNA Biomarkers for Prostate Cancer

Short, noncoding regulatory stretches of RNA known as microRNA hold promise as prostate cancer biomarkers.

Looking to the Genome for Prostate Cancer Biomarkers

Looking to the Genome for Prostate Cancer Biomarkers

Researchers are trying to develop prostate cancer biomarkers that can predict treatment effects, to spare patients toxicities associated with unhelpful regimens.

Tailoring Melanoma Prevention With Personalized Risk Factors

Tailoring Melanoma Prevention With Personalized Risk Factors

Researchers have identified risk factors that can help clinicians tailor preventative surveillance in high-risk melanoma.

A View of the Current and Future Treatment Landscapes in Renal Cell Carcinoma

A View of the Current and Future Treatment Landscapes in Renal Cell Carcinoma

Although there was hope that biomarkers may aid in treatment selection, research efforts to date have not yielded a viable option.

HIPEC in Colorectal Cancer With Peritoneal Carcinomatosis

HIPEC in Colorectal Cancer With Peritoneal Carcinomatosis

CRS and HIPEC appear to have promising data when used in the optimal patient population.

Cardiac Side Effects May Occur With Immune Checkpoint Inhibitor Combination

Cardiac Side Effects May Occur With Immune Checkpoint Inhibitor Combination

These toxicities are rare, though it is unclear how physicians can screen for them.

Age Correlates With Incidence of RCC Among Pediatric Patients With Renal Malignancy

Age Correlates With Incidence of RCC Among Pediatric Patients With Renal Malignancy

Researchers found that age and tumor size were the most significant factors for predicting renal cell carcinoma (RCC).

Darwinian Oncology Comes of Age: Evolutionary Biologists Offer Competing Theories of Cancer

Darwinian Oncology Comes of Age: Evolutionary Biologists Offer Competing Theories of Cancer

Proponents of competing evolutionary theories seek to explain—and combat—oncogenesis.

How Should Maintenance Therapy for Multiple Myeloma Be Prescribed?

How Should Maintenance Therapy for Multiple Myeloma Be Prescribed?

Researchers reviewed current research on maintenance therapy for multiple myeloma and provided recommendations for its application.

Financial Hardship Common Among Cancer Survivors and Warrants Patient-Provider Discussion

Financial Hardship Common Among Cancer Survivors and Warrants Patient-Provider Discussion

Financial hardship is common among cancer survivors in the US, and can be a psychologically and economically debilitating burden.

Catumaxomab for Malignant Ascites Associated With Gastric Cancer

Catumaxomab for Malignant Ascites Associated With Gastric Cancer

Trifunctional antibodies such as catumaxomab may have a significant impact in treating these malignancies.

"Beat AML" Master Trial Aims To Be Leader in Precision Medicine

"Beat AML" Master Trial Aims To Be Leader in Precision Medicine

This collaborative trial will test several new drugs in the clinical setting at major research institutions.

Institutional Care Volume May Affect Clinical Outcomes in Multiple Myeloma

Institutional Care Volume May Affect Clinical Outcomes in Multiple Myeloma

High-volume treatment centers tend to produce better clinical outcomes, but volume isn't a necessary predictor of survival rates.

The US Health Care System Should Prepare and Participate in Changing Payment Models

The US Health Care System Should Prepare and Participate in Changing Payment Models

Single bundle payments may be as effective for treatment, and much less expensive, than fee-for-service programs in health care.

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters